Discuss This Drug

rilonacept

CHEBI:CHEBI_747793

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
rilonacept
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
route
SUBCUTANEOUS
active_ingredient_strength
160 mg/2mL
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
DRUG FOR FURTHER PROCESSING
package_marketing_start_date
20080324
labeler_name
Kiniksa Pharmaceuticals (UK), Ltd.
product_ndc
61755-931
marketing_start_date
20080227
spl_id
2bcb722e-e21a-46ed-9582-e4f49b872df6
active_ingredient_name
RILONACEPT
package_ndc
61755-931-00
package_description
1000 mL in 1 BOTTLE (61755-931-00)
brand_name
Arcalyst
brand_name_base
Arcalyst
application_number
BLA125249
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class